Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Efficacy of AI-Augmented Cognitive Rehabilitation in Mild Cognitive Impairment

NCT07474038 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT07474038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07474038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Efficacy of AI-Augmented Cognitive Rehabilitation in Mild Cognitive Impairment
Lead sponsor
Kaiser Permanente
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
March 16, 2026
Completion date
December 31, 2027
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment (mci)